University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

The Share Health Study: Teen Social Connections and Health

Not Applicable

Completed

Conditions: Contraception

Interventions: Behavioral: Alcohol Control Intervention
Behavioral: SpeakOut

First Posted Date: 2016-06-07

Last Posted Date: 2018-11-27

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 207

Registration Number: NCT02791971

Locations: 🇺🇸
University of California, San Francisco, Davis, California, United States
🇺🇸
University of Southern California Keck School of Medicine, Los Angeles, California, United States

N-acetylcysteine Treatment of Alcohol Use Disorder In Veterans With TBI

Phase 2

Completed

Conditions: Hazardous and Harmful Alcohol Use
Traumatic Brain Injury (TBI)

Interventions: Behavioral: Medical Management Counseling
Drug: Placebo
Drug: N-acetylcysteine

First Posted Date: 2016-06-07

Last Posted Date: 2021-05-11

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 30

Registration Number: NCT02791945

Locations: 🇺🇸
San Francisco VA Medical Center, San Francisco, California, United States

Sorting and Expression Profiling of Airway Cells From Humans (The SEARCH Study)

Completed

Conditions: Asthma

First Posted Date: 2016-06-06

Last Posted Date: 2024-02-05

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 32

Registration Number: NCT02791542

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Feasibility And Efficacy Of An iPad-Based Cognitive Rehabilitation Program In Brain Tumor Patients

Not Applicable

Terminated

Conditions: Glioma

First Posted Date: 2016-05-26

Last Posted Date: 2020-01-18

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 11

Registration Number: NCT02783495

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

A Feasibility Study of Gallium-68 Citrate PET to Detect Aberrant MYC Proto-Oncogene, BHLH Transcription Factor (MYC) Protein Expression in Diffuse Large B-Cell Lymphoma

Phase 2

Withdrawn

Conditions: Lymphoma, Large B-Cell, Diffuse
Burkitt Lymphoma

Interventions: Drug: Gallium citrate

First Posted Date: 2016-05-18

Last Posted Date: 2019-10-10

Lead Sponsor: University of California, San Francisco

Registration Number: NCT02776891

Dopamine Responsivity in Gamblers

Not Applicable

Completed

Conditions: Pathological Gambling

Interventions: Drug: Placebo
Drug: Tolcapone

First Posted Date: 2016-05-16

Last Posted Date: 2021-02-16

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 19

Registration Number: NCT02772978

Effect of Betaine and Food on Gastric pH

Not Applicable

Completed

Conditions: Healthy

Interventions: Other: Standardized Meal
Dietary Supplement: Betaine Hydrochloride 3000mg
Dietary Supplement: Betaine Hydrochloride 1500mg
Dietary Supplement: Betaine Hydrochloride 4500mg

First Posted Date: 2016-05-02

Last Posted Date: 2020-01-23

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 9

Registration Number: NCT02758015

Locations: 🇺🇸
Clinical Research Center, UCSF, San Francisco, California, United States

Sanitation, Water, and Instruction in Face-washing for Trachoma I/II

Phase 3

Active, not recruiting

Conditions: Trachoma

Interventions: Other: Control
Behavioral: Water, sanitation, and hygiene (WASH) intervention
Behavioral: Standard of care WASH intervention
Drug: Azithromycin
Drug: Tetracycline

First Posted Date: 2016-04-28

Last Posted Date: 2025-03-07

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 340000

Registration Number: NCT02754583

Locations: 🇪🇹
The Carter Center Ethiopia, Addis Ababa, Ethiopia

A Trial of Doxycycline in Renal Disease

Phase 1

Completed

Conditions: Cardiorenal Syndrome
Chronic Kidney Disease

Interventions: Drug: Doxycycline
Drug: Placebo (for Doxycycline)

First Posted Date: 2016-04-27

Last Posted Date: 2020-02-06

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 11

Registration Number: NCT02753426

Locations: 🇺🇸
Zuckerberg San Francisco General Hospital, San Francisco, California, United States

SFGH Health Advocates Stage II Study

Not Applicable

Completed

Conditions: Conditions Influencing Health Status
Social Determinants of Health

Interventions: Other: Health Advocates Program
Other: 211 Information Sheet

First Posted Date: 2016-04-21

Last Posted Date: 2020-10-06

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 1278

Registration Number: NCT02746393

Locations: 🇺🇸
San Francisco General Hospital, San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy